Antibe Therapeutics Inc.
ATBPF
Price:
$0.216
Market Cap:
$16.01M
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. Its lead compound is Otenaproxesul, a hydrogen sulfide-releasing derivative of naproxen for treating post-operative pain, migraine, dysmenorrhea, traumatic injury, dental pain, and gout that has completed Phase 2B gastrointestinal safety study. In addition, the company's products comprise ATB-352, which is in preclinical stage for a...[Read more]
Industry
Medical - Devices
IPO Date
2014-10-09
Stock Exchange
PNK
Ticker
ATBPF
PE Ratio
[-0.86]
ROE
[-49.77%]
Current Ratio
[10.06]
Dividend Yield
[0%]
Enterprise Value
[4.67M]
Dividend History
The ROE as of November 2024 (TTM) for Antibe Therapeutics Inc. (ATBPF) is -49.77%
According to Antibe Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -49.77%. This represents a change of 240.00% compared to the average of -14.64% of the last 4 quarters.
Antibe Therapeutics Inc. (ATBPF) Historical ROE (quarterly & annually)
How has ATBPF ROE performed in the past?
The mean historical ROE of Antibe Therapeutics Inc. over the last ten years is -252.57%. The current -49.77% ROE has changed -80.29% with respect to the historical average. Over the past ten years (40 quarters), ATBPF's ROE was at its highest in in the December 2021 quarter at -7.92%. The ROE was at its lowest in in the March 2015 quarter at -192.41%.
Average
-252.57%
Median
-86.96%
Minimum
-1305.25%
Maximum
-44.09%
Antibe Therapeutics Inc. (ATBPF) ROE by Quarter and Year
Discovering the peaks and valleys of Antibe Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.52%
Maximum Annual ROE = -44.09%
Minimum Annual Increase = -177.80%
Minimum Annual ROE = -1305.25%
| Year | ROE | Change |
|---|---|---|
| 2023 | -48.49% | 9.96% |
| 2022 | -44.09% | -15.73% |
| 2021 | -52.33% | -89.78% |
| 2020 | -511.83% | 197.16% |
| 2019 | -172.24% | 84.88% |
| 2018 | -93.16% | -42.38% |
| 2017 | -161.70% | 189.31% |
| 2016 | -55.89% | -95.72% |
| 2015 | -1305.25% | 1.52% |
| 2014 | -80.76% | -177.80% |
Antibe Therapeutics Inc. (ATBPF) Average ROE
How has ATBPF ROE performed in the past?
The current ROE of Antibe Therapeutics Inc. (ATBPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-48.30%
5-year avg
-165.80%
10-year avg
-252.57%
Antibe Therapeutics Inc. (ATBPF) ROE vs. Peers
How is ATBPF’s ROE compared to its peers?
Antibe Therapeutics Inc.’s ROE is greater than Biotron Limited (-504.53%), less than Bioasis Technologies Inc. (0%), greater than Covalon Technologies Ltd. (-4.23%), less than Mosaic ImmunoEngineering Inc. (5.79%), greater than Ceapro Inc. (-21.67%), greater than Cellectis S.A. (-76.69%), less than Adynxx, Inc. (0%), less than AVAX Technologies, Inc. (0%), greater than BioCardia, Inc. (-344.15%), less than Adial Pharmaceuticals, Inc. WT EXP 073123 (1.00%), greater than null (-256.25%),
| Company | ROE | Market cap |
|---|---|---|
| -504.53% | $11.30M | |
| 0% | $284.08K | |
| -4.23% | $72.60M | |
| 5.79% | $7.24M | |
| -21.67% | $13.31M | |
| -76.69% | $183.12M | |
| 0% | $581.00 | |
| 0% | $6.89K | |
| -344.15% | $10.12K | |
| 1.00% | $0 | |
| -256.25% | $0 |
Build a custom stock screener for Antibe Therapeutics Inc. (ATBPF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Antibe Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Antibe Therapeutics Inc. (ATBPF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Antibe Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Antibe Therapeutics Inc.'s ROE?
How is the ROE calculated for Antibe Therapeutics Inc. (ATBPF)?
What is the highest ROE for Antibe Therapeutics Inc. (ATBPF)?
What is the 3-year average ROE for Antibe Therapeutics Inc. (ATBPF)?
What is the 5-year average ROE for Antibe Therapeutics Inc. (ATBPF)?
How does the current ROE for Antibe Therapeutics Inc. (ATBPF) compare to its historical average?